1. Blanchard, A.A., Skliris, G.P., Watson, P.H., Murphy, L.C., Penner, C., Tomes, L., Young, T.L., Leygue, E. & Myal, Y. (2009) Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch., 454, 647-656.
2. Cai, C., Wang, H., He, H.H., Chen, S., He, L., Ma, F., Mucci, L., Wang, Q., Fiore, C., Sowalsky, A.G., Loda, M., Liu, X.S., Brown, M., Balk, S.P. & Yuan, X. (2013) ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer. J. Clin. Invest., 123, 1109-1122.
3. Clark, P.M., Dawany, N., Dampier, W., Byers, S.W., Pestell, R.G. & Tozeren, A. (2012) Bioinformatics analysis reveals transcriptome and microRNA signatures and drug repositioning targets for IBD and other autoimmune diseases. Inflamm. Bowel Dis., 18, 2315-2333.
4. Darido, C., Buchert, M., Pannequin, J., Bastide, P., Zalzali, H., Mantamadiotis, T., Bourgaux, J.F., Garambois, V., Jay, P., Blache, P., Bleach, P., Joubert, D. & Hollande, F. (2008) Defective claudin-7 regulation by Tcf-4 and SOX-9 disrupts the polarity and increases the tumorigenicity of colorectal cancer cells. Cancer Res., 68, 4258-4268.
5. Fagioli, F., Aglietta, M., Tienghi, A., Ferrari, S., Branch del Prever, A., Vassallo, E., Palmero, A., Biasin, E., Bacci, G., Picci, P. & Madon, E. (2002) High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. J. Clin. Oncol., 20, 2150-2156.